INVO Bioscience INVO reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
INVO Bioscience beat estimated earnings by 4.17%, reporting an EPS of $-0.23 versus an estimate of $-0.24.
Revenue was down $62 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 0.96% drop in the share price the next day.
Here's a look at INVO Bioscience's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.25 | -0.22 | -0.20 | -0.19 |
EPS Actual | -0.23 | 0.03 | -0.24 | -0.17 |
Revenue Estimate | 240K | 210K | 330K | 410K |
Revenue Actual | 162K | 3.05M | 218K | 208K |
To track all earnings releases for INVO Bioscience visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.